Home A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen
Article
Licensed
Unlicensed Requires Authentication

A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen

  • Xiao-Li Kong , Hui Qi , Han-Xin Zhou , Li-Li Ren , Chong-Yan Deng and Fu-Rong Li
Published/Copyright: December 10, 2009

Abstract

Background: The sensitivity and selectivity of traditional methods limits ultramicro detection of proteins. Bio-barcode amplification detection methods based on nanotechnology enables ultramicro detection of protein. However, bio-barcode amplification detection depends on the oligonucleotides being fixed on a glass chip. It also requires specialized equipment, which limits its application. We introduce a nano-nucleic acid barcode dot detection technology to determine ultramicro concentrations of protein. The method is simple, quick and accurate.

Methods: Magnetic probe (IgG-M) and dual-labeled gold nanoparticle bio-probe (IgG-Au-DNA) were prepared. Protein was captured using a sandwich assay technique and magnetic separation was used. The DNA barcode was released with dithiothreitol (DTT) and detected directly without the requirement for polymerase chain reaction (PCR). Serum prostate-specific antigen (PSA) from 135 patients was detected with this method and compared with enzyme linked immunosorbent assay (ELISA) and radioimmunoassay (RIA).

Results: Each IgG-Au-DNA could be covered with 138±47 oligonucleotides and 11±3 antibodies. The IgG-M could bind 118 μg of antibody per mg. The sensitivity of nano-nucleic acid barcode dot detection technology might allow detection of 1 fg/mL. There were no significant differences in serum PSA from 135 patients when comparing the three methods (compared with ELISA, r=0.950; and with RIA, r=0.967).

Conclusions: The nucleic acid barcode dot method does not require special equipment or complex procedures, but its detection limit is 2–3 orders of magnitude lower than ELISA.

Clin Chem Lab Med 2010;48:279–83.


Corresponding author: Fu-Rong Li, Clinical Medical Research Center, The 2nd Clinic Medicine College, Jinan University, No. 1017 Dongmen North Road, Shenzhen 518020, Guangdong Province, P.R. China Phone: +86-755-25533018, Fax: +86-755-25533497,

Received: 2009-8-17
Accepted: 2009-10-6
Published Online: 2009-12-10
Published in Print: 2010-02-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review
  3. Minireview
  4. Artificial intelligence for diagnostic purposes: principles, procedures and limitations
  5. General Clinical Chemistry and Laboratory Medicine
  6. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006
  7. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
  8. Plasma osteopontin concentrations in preeclampsia – is there an association with endothelial injury?
  9. Determination of globotriaosylceramide in plasma and urine by mass spectrometry
  10. Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis
  11. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin
  12. Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements
  13. O-β-N-acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots
  14. Validation and Outcome Studies
  15. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
  16. Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
  17. Reference Values and Biological Variations
  18. Applicability of common reference intervals for serum creatinine concentrations to the Croatian population
  19. Laboratory reference intervals during pregnancy, delivery and the early postpartum period
  20. Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory
  21. Definition of reference ranges for the platelet distribution width (PDW): a local need
  22. Cancer Diagnostics
  23. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study
  24. Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma
  25. Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
  26. A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen
  27. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access® prostate-specific antigen assays
  28. Infectious Diseases
  29. Use of flow cytometry (Sysmex® UF-100) to screen for positive urine cultures: in search for the ideal cut-off
  30. Letters to the Editor
  31. Improving laboratory efficiencies through significant time reduction in the preanalytical phase
  32. Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp.
Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.041/html
Scroll to top button